Go to our new-look site, it combines the Biotechnology and Science Learning Hubs with a new look and new functionality. This is our legacy site and is no longer maintained.

Skip to page content

Site navigation

Biotech product development

There are many aspects to consider when you are taking a biotech product from the initial stages of design through testing and into the market place.

Planning is key to development

Product development is part of all biotechnology projects. Planning at the very beginning of each project is crucial.

It takes more than just a good idea to create a successful, marketable biotech product. From the design stages to full-scale production, science has to work hand-in-hand with market research, legal expertise, financial backers and government authorities. This takes through planning and good communication.

The following information sheets give additional details:
Legal issues
Modelling and testing

The original plan must be regularly updated as progress is made and markets or legal requirements change.

A New Zealand example

One example of a biotech product being developed in New Zealand is VivaGel™. VivaGel™ prevents the spread of human immunodeficiency virus (HIV) by grabbing hold of the virus and destroying it.

VivaGel™ is being developed jointly by Industrial Research Limited (IRL) and Australian biotech company Starpharma. In January 2006, the United States Food and Drug Administration (FDA) approved use of VivaGel in the US, and it is currently undergoing clinical trials.

Get information sheet: Aids and VivaGel™


Return to top